1.91
前日終値:
$1.79
開ける:
$1.75
24時間の取引高:
357.29K
Relative Volume:
0.17
時価総額:
$41.77M
収益:
$1.38M
当期純損益:
$-179.05M
株価収益率:
-0.3111
EPS:
-6.14
ネットキャッシュフロー:
$-155.03M
1週間 パフォーマンス:
+17.18%
1か月 パフォーマンス:
-13.18%
6か月 パフォーマンス:
+37.41%
1年 パフォーマンス:
+234.74%
Bioxcel Therapeutics Inc Stock (BTAI) Company Profile
名前
Bioxcel Therapeutics Inc
セクター
電話
203-643-8060
住所
555 LONG WHARF DRIVE, NEW HAVEN, CT
BTAI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BTAI
Bioxcel Therapeutics Inc
|
1.91 | 39.15M | 1.38M | -179.05M | -155.03M | -6.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Bioxcel Therapeutics Inc Stock (BTAI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-02-21 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-15 | ダウングレード | Mizuho | Buy → Neutral |
| 2023-07-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-03-10 | ダウングレード | Jefferies | Buy → Hold |
| 2022-12-01 | アップグレード | Goldman | Sell → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-06 | 繰り返されました | BofA Securities | Buy |
| 2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
| 2021-04-09 | 開始されました | Berenberg | Buy |
| 2021-02-01 | 開始されました | UBS | Buy |
| 2020-10-30 | 開始されました | Goldman | Buy |
| 2020-09-02 | 開始されました | Jefferies | Buy |
| 2020-08-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-04 | 開始されました | Guggenheim | Buy |
| 2020-04-01 | 開始されました | BofA/Merrill | Buy |
| 2020-02-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-01-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-12 | 開始されました | SunTrust | Buy |
すべてを表示
Bioxcel Therapeutics Inc (BTAI) 最新ニュース
FDA Approves New Indication for BioXcel Therapeutics' Igalmi (BTAI) - GuruFocus
Why BioXcel Therapeutics Inc. (BX20) stock could be next leaderMarket Volume Summary & AI Enhanced Trading Alerts - newser.com
Can BioXcel Therapeutics Inc. stock deliver consistent earnings growthEarnings Recap Summary & Consistent Return Investment Signals - newser.com
Is BioXcel Therapeutics Inc. stock attractive after correctionQuarterly Market Summary & Expert Approved Momentum Ideas - newser.com
Why BioXcel Therapeutics Inc. (BX20) stock is listed among top recommendationsEarnings Recap Summary & Fast Entry Momentum Trade Alerts - newser.com
Will BioXcel Therapeutics Inc. stock see PE expansionJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Can BioXcel Therapeutics Inc. (BX20) stock sustain free cash flow2025 Technical Overview & Free Weekly Watchlist of Top Performers - newser.com
Can BioXcel Therapeutics Inc. stock beat market expectations this quarterTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Is BioXcel Therapeutics Inc. (BX20) stock vulnerable to rate hikesChart Signals & Daily Entry Point Alerts - newser.com
What dividend safety score for BioXcel Therapeutics Inc. stockEarnings Miss & Community Verified Trade Signals - newser.com
Looking at the Narrative for BioXcel Therapeutics After Fair Value Reset and Clinical Milestones - Yahoo Finance
Can you recover from losses in BioXcel Therapeutics Inc.Short Setup & Capital Efficient Trade Techniques - newser.com
Does BioXcel Therapeutics Inc. show high probability of reboundJuly 2025 Chart Watch & AI Forecasted Entry and Exit Points - newser.com
Will BioXcel Therapeutics Inc. (BX20) stock recover faster than industryJuly 2025 Update & AI Forecast Swing Trade Picks - newser.com
How BioXcel Therapeutics Inc. (BX20) stock reacts to stronger dollarJuly 2025 Summary & Verified Technical Signals - newser.com
Key metrics from BioXcel Therapeutics Inc.’s quarterly dataJuly 2025 Highlights & Free Verified High Yield Trade Plans - newser.com
Will BioXcel Therapeutics Inc. stock benefit from automationDay Trade & Free Risk Controlled Daily Trade Plans - newser.com
BioXcel Therapeutics (BTAI) Price Target Increased by 15.68% to 21.83 - Nasdaq
Bioxcel Therapeutics Inc (BTAI) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):